EDAP TMS reported EUR-4.92M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AngioDynamics USD -2.51M 5.41M Sep/2025
Boston Scientific USD 1.05B 190M Mar/2026
EDAP TMS EUR -4.92M 843K Sep/2025
Henry Schein USD 182M 4M Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Veracyte USD 19.08M 5.55M Mar/2026